Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives.

Zoltán KalóZsuzsanna Ida PetykóFrank-Ulrich FrickeNikos ManiadakisTomáš TesařKateřina PodrazilováJaime EspinAndras Inotai

Published in: Cost effectiveness and resource allocation : C/E (2021)

The core evaluation framework for VAMs could trigger changes in the existing pricing, reimbursement and procurement practices by improving the appraisal of the added value created by incremental innovation.

Keyphrases

healthcare
primary care
public health
mental health